Drugs & TargetsFree Cologuard earns positive review from Blue Cross Blue Shield Association January 13, 2017Vol.43 No.02
Drugs & TargetsFree FDA accepts BLA for Mylan and Biocon’s biosimilar Trastuzumab January 13, 2017Vol.43 No.02
Drugs & TargetsFree FDA releases guidance on nonproprietary naming of biologics January 13, 2017Vol.43 No.02
Drugs & TargetsFree Strata Trial study launched with UNC, Alabama cancer centers January 06, 2017Vol.43 No.01
Drugs & TargetsFree Foundation Medicine receives FDA approval as companion diagnostic January 06, 2017Vol.43 No.01
Drugs & TargetsFree Ionis gets $28 million from AstraZeneca for new cancer drug January 06, 2017Vol.43 No.01
Drugs & TargetsFree MaxCyte, Washington University in St. Louis announce collaboration January 06, 2017Vol.43 No.01
Drugs & TargetsFree MD Anderson, Affimed collaborate on immunotherapy combination January 06, 2017Vol.43 No.01
